Incidental Mutation 'R9153:Fxyd2'
ID 695156
Institutional Source Beutler Lab
Gene Symbol Fxyd2
Ensembl Gene ENSMUSG00000059412
Gene Name FXYD domain-containing ion transport regulator 2
Synonyms Atp1g1
MMRRC Submission 068940-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R9153 (G1)
Quality Score 225.009
Status Validated
Chromosome 9
Chromosomal Location 45311007-45321576 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to T at 45319609 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Valine to Phenylalanine at position 24 (V24F)
Ref Sequence ENSEMBL: ENSMUSP00000035429 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000041005] [ENSMUST00000213850] [ENSMUST00000214257] [ENSMUST00000214466] [ENSMUST00000216289]
AlphaFold no structure available at present
Predicted Effect probably damaging
Transcript: ENSMUST00000041005
AA Change: V24F

PolyPhen 2 Score 0.994 (Sensitivity: 0.69; Specificity: 0.97)
SMART Domains Protein: ENSMUSP00000035429
Gene: ENSMUSG00000059412
AA Change: V24F

DomainStartEndE-ValueType
Pfam:ATP1G1_PLM_MAT8 10 60 1.6e-27 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000213850
Predicted Effect probably benign
Transcript: ENSMUST00000214257
Predicted Effect probably damaging
Transcript: ENSMUST00000214466
AA Change: V24F

PolyPhen 2 Score 0.998 (Sensitivity: 0.27; Specificity: 0.99)
Predicted Effect probably damaging
Transcript: ENSMUST00000216289
AA Change: V24F

PolyPhen 2 Score 0.994 (Sensitivity: 0.69; Specificity: 0.97)
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.7%
  • 20x: 98.9%
Validation Efficiency 99% (73/74)
MGI Phenotype FUNCTION: This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. The Type III integral membrane protein encoded by this gene is the gamma subunit of the Na,K-ATPase present on the plasma membrane. Although the Na,K-ATPase does not depend on the gamma subunit to be functional, it is thought that the gamma subunit modulates the enzyme's activity by inducing ion channel activity. Multiple transcript variants have been described for this gene that are expressed in tissue-specific and developmental stage-specific patterns and encode proteins that differ at the N-terminus. [provided by RefSeq, Sep 2009]
PHENOTYPE: Homozygous null mice are viable and fertile but display abnormal renal NaK-ATPase kinetics. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 75 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abca6 A T 11: 110,107,481 (GRCm39) S711R possibly damaging Het
Adnp C A 2: 168,026,580 (GRCm39) Q238H possibly damaging Het
Akap13 A G 7: 75,259,229 (GRCm39) T618A probably benign Het
Ankfn1 G A 11: 89,302,845 (GRCm39) R58W probably damaging Het
Atp8b5 A G 4: 43,308,493 (GRCm39) probably benign Het
Borcs5 G T 6: 134,618,108 (GRCm39) probably benign Het
C1s1 T C 6: 124,517,906 (GRCm39) M25V possibly damaging Het
Canx A T 11: 50,188,162 (GRCm39) D527E probably benign Het
Ccdc154 G A 17: 25,382,152 (GRCm39) D24N probably damaging Het
Ccnt1 G A 15: 98,441,159 (GRCm39) T703I probably benign Het
Cd46 T C 1: 194,774,479 (GRCm39) S19G possibly damaging Het
Cdc25b G A 2: 131,034,564 (GRCm39) E264K possibly damaging Het
Cdhr17 A T 5: 17,040,916 (GRCm39) probably null Het
Cog5 A C 12: 31,710,810 (GRCm39) K63N possibly damaging Het
Col28a1 G A 6: 8,022,765 (GRCm39) T726I probably benign Het
Dhx40 A G 11: 86,690,365 (GRCm39) S219P probably damaging Het
Dnah12 T A 14: 26,536,569 (GRCm39) W2162R probably damaging Het
Eef1a2 A G 2: 180,789,774 (GRCm39) *464R probably null Het
Eif1a T A 18: 46,741,036 (GRCm39) D90E probably damaging Het
Fasn C T 11: 120,706,496 (GRCm39) R996Q possibly damaging Het
Foxred2 A G 15: 77,839,787 (GRCm39) probably null Het
Frat2 A G 19: 41,835,806 (GRCm39) L182P probably damaging Het
Gabrd C T 4: 155,470,496 (GRCm39) V319I probably damaging Het
H13 T G 2: 152,533,788 (GRCm39) V267G possibly damaging Het
Hnf4g T C 3: 3,573,378 (GRCm39) probably benign Het
Iglon5 T A 7: 43,125,421 (GRCm39) T272S possibly damaging Het
Iqgap2 T A 13: 95,844,547 (GRCm39) M454L probably benign Het
Irf8 T C 8: 121,480,400 (GRCm39) C304R probably benign Het
Itga2 A G 13: 115,001,941 (GRCm39) F614L probably benign Het
Itgb4 A C 11: 115,874,879 (GRCm39) H412P probably benign Het
Jarid2 T C 13: 45,064,678 (GRCm39) F921S probably damaging Het
Kctd13 A G 7: 126,541,327 (GRCm39) D189G probably damaging Het
Meis2 G T 2: 115,697,756 (GRCm39) P381T probably benign Het
Mertk G T 2: 128,624,487 (GRCm39) A633S probably damaging Het
Morn5 A G 2: 35,942,993 (GRCm39) Y31C probably damaging Het
Mug2 A T 6: 122,017,627 (GRCm39) T455S possibly damaging Het
Myo3a A G 2: 22,404,744 (GRCm39) N700S probably benign Het
Nisch T C 14: 30,896,782 (GRCm39) T807A unknown Het
Nkx1-1 A T 5: 33,588,703 (GRCm39) V195E unknown Het
Numa1 A G 7: 101,649,118 (GRCm39) T950A probably benign Het
Nup160 A G 2: 90,514,429 (GRCm39) T126A possibly damaging Het
Oca2 C T 7: 55,943,586 (GRCm39) T253I probably benign Het
Odad2 T C 18: 7,286,733 (GRCm39) K166R possibly damaging Het
Or6c209 T A 10: 129,483,306 (GRCm39) I103N possibly damaging Het
P4ha1 A G 10: 59,203,112 (GRCm39) K435R probably damaging Het
Pcdhgb4 T A 18: 37,854,131 (GRCm39) N175K possibly damaging Het
Per3 A G 4: 151,111,796 (GRCm39) L396P probably benign Het
Phactr3 A T 2: 177,925,739 (GRCm39) E338V possibly damaging Het
Plec G T 15: 76,064,725 (GRCm39) R1782S unknown Het
Prpf39 A T 12: 65,106,671 (GRCm39) Q593L probably damaging Het
Ptprq T C 10: 107,416,126 (GRCm39) Y1724C probably damaging Het
Pygo1 T A 9: 72,852,143 (GRCm39) V110D possibly damaging Het
Rasgrf1 T A 9: 89,826,790 (GRCm39) L133Q probably damaging Het
Rgs10 G A 7: 127,975,733 (GRCm39) R145C probably damaging Het
Secisbp2 A G 13: 51,833,855 (GRCm39) Y665C possibly damaging Het
Sel1l3 T A 5: 53,293,188 (GRCm39) T843S probably benign Het
Senp7 G A 16: 56,006,486 (GRCm39) V964I probably benign Het
Setd4 T A 16: 93,384,722 (GRCm39) D322V possibly damaging Het
Sftpc T A 14: 70,759,650 (GRCm39) T90S probably benign Het
Shq1 A T 6: 100,588,738 (GRCm39) D382E probably damaging Het
Sim1 A G 10: 50,772,029 (GRCm39) R13G probably damaging Het
Slc12a1 T G 2: 125,002,989 (GRCm39) probably benign Het
Slc27a6 T C 18: 58,731,805 (GRCm39) F385S probably benign Het
Stk38l A G 6: 146,660,048 (GRCm39) T27A probably benign Het
Tasp1 A G 2: 139,899,327 (GRCm39) S9P probably damaging Het
Tcstv1a T A 13: 120,355,290 (GRCm39) D114V probably damaging Het
Tmigd1 A T 11: 76,795,468 (GRCm39) R25S probably benign Het
Tnrc6a T A 7: 122,773,519 (GRCm39) Y1154N probably damaging Het
Tox2 T C 2: 163,045,091 (GRCm39) V3A Het
Ubr1 A T 2: 120,756,469 (GRCm39) D719E probably benign Het
Ubr3 A G 2: 69,795,822 (GRCm39) K923R Het
Vmn2r12 C T 5: 109,234,203 (GRCm39) V670M probably damaging Het
Zfp983 T C 17: 21,876,522 (GRCm39) S9P probably benign Het
Zfp986 A T 4: 145,626,030 (GRCm39) H230L probably damaging Het
Zscan4f G A 7: 11,135,241 (GRCm39) E216K probably benign Het
Other mutations in Fxyd2
AlleleSourceChrCoordTypePredicted EffectPPH Score
R5969:Fxyd2 UTSW 9 45,319,628 (GRCm39) missense probably damaging 1.00
R6415:Fxyd2 UTSW 9 45,314,592 (GRCm39) missense possibly damaging 0.81
R8999:Fxyd2 UTSW 9 45,314,295 (GRCm39) intron probably benign
Predicted Primers PCR Primer
(F):5'- TCCCTTCGAGTACGGTAAGC -3'
(R):5'- TACTCAAGGGATAGGGTGGC -3'

Sequencing Primer
(F):5'- TAAGCCGGTCCTCCCCTG -3'
(R):5'- AGTTGCCCAGCCAGACTTC -3'
Posted On 2022-01-20